We are excited to announce that we have recently launched two new products at the Clinical Pharmacy Congress 2019 in London, Ganciclovir 500mg, Eptifibatide 0.75mg/ml and Eptifibatide 2mg/ml.
The CPC is the largest gathering for the clinical pharmacy profession in Europe. It provides teams with an unmissable opportunity to keep up to date with the latest pharmacy developments whilst gaining new insights and inspiration enhance knowledge and improve patient outcomes.
For our Kensington team it was a great opportunity to discuss our current development of dependable, clinically effective and cost effective injectables, designed around the needs of the patient. It was a pleasure to see so many valued customers visit our stand to discuss how Kensington Pharma’s current and upcoming portfolio of products can optimise the effectiveness for their patients and assist them in their clinical practice. Please see pictures of our exhibition stand and team in action below.
